Superstring Capital Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
Other funds holding ASND
Superstring Capital Management's ASND Position: Q2 2024 in Review
Superstring Capital Management sold out of Ascendis Pharma (ASND) in Q2 2024, closing a stake of 12,754 shares — an estimated $1.93M sold.
Superstring Capital Management first reported a position in ASND in Q1 2024 and held it in 1 quarter. The position peaked at $1.93M in Q1 2024. 203 funds tracked by Wall St. Rank hold ASND as of Q2 2024.
- Superstring Capital Management reported no remaining Ascendis Pharma position as of Q2 2024 after selling out during the quarter.
- Superstring Capital Management sold 12,754 Ascendis Pharma shares in Q2 2024, an estimated $1.93M.
- Superstring Capital Management first reported a position in Ascendis Pharma in Q1 2024 and held it in 1 quarter.
- Superstring Capital Management's Ascendis Pharma position peaked at $1.93M in Q1 2024.
- 203 funds tracked by Wall St. Rank held Ascendis Pharma as of Q2 2024.
Based on Superstring Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.